scorecardresearch
Add as a preferred source on Google
Saturday, February 21, 2026
TopicHIV

Topic: HIV

China’s method to boost birth rates in country – adding tax to condoms

Under the revised value-added tax law, consumers will pay a 13% levy on items that had been exempted since 1993, when China enforced a strict one-child policy.

Safe access to HIV medication is wrapped in stigma. This non-profit is changing that

Getting quick access to PEP is important because the course must be started within 72 hours of a potential exposure to HIV to be effective. That's the gap the directory aims to fill.

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

What is Hyderabad’s role in global acetone trade? New book explores the city beyond biryani

In 'Beyond Biryani', journalist Dinesh C Sharma unpacks the city's identity beyond its clichés and stereotypes, highlighting its contributions to industrial & scientific breakthroughs.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Meth addiction, HIV, and a struggling health system plague Fiji as tourism grows

With children as young as nine being treated for addiction, and with crime statistics and HIV and AIDS cases climbing dramatically, police have called for a state of emergency.

Llama nanobodies can target HIV-1 strains & Sun starts next solar cycle halfway throught current one

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

Global life expectancy on the rise — men and women to live more than 4 years longer by 2050

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

New lead for AIDS treatment? IISER scientists identify circular RNA that helps HIV-1 virus multiply

Findings published in journal Science Advances. The scientists have also developed a protein molecule that can reduce the multiplication of the HIV virus.

On Camera

Youth Congress, your foolish protest helped the Modi govt climb out of the AI summit hole

In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

MoD, IAF agree on some exemptions to HAL for Tejas Mk1A, but no compromise on ‘must-have’ capabilities

IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.